News
Men's Health & TestosteroneThe Lancet Diabetes & Endocrinology

The Lancet: Osteoporosis in Men Has Been Overlooked for Too Long

February 5, 2024

Nearly 25% of men over 50 will suffer an osteoporotic fracture, yet fewer than 6% receive bone density screening. The Lancet calls male osteoporosis one of medicine's most overlooked conditions.

Read the original article at The Lancet Diabetes & Endocrinology

Kairos™'s Take

Kairos™'s perspective on this story

When most people hear the word osteoporosis, they think of postmenopausal women. That assumption is costing men their mobility and their lives. The Lancet Diabetes & Endocrinology published an editorial in 2020 with a blunt title: "Osteoporosis: overlooked in men for too long." The data behind that headline is damning. Nearly 25% of men over 50 will break a bone due to osteoporosis, yet in the two years preceding their fracture, fewer than 6% of men had their bone mineral density measured.

The treatment gap is even worse than the screening gap. Among older men who experienced a fracture, only 2.1% were both diagnosed with osteoporosis and treated. Another 2.8% were diagnosed but not treated, and 2.3% were treated but not diagnosed. That means roughly 93% of men who broke bones due to osteoporosis fell completely through the clinical safety net.

Male osteoporosis also carries a higher mortality burden than the female form. Men who sustain hip fractures have a significantly higher death rate in the following year compared to women with the same injury. The condition is not rarer in men because men are inherently protected; it is rarer in diagnosis because clinicians systematically underestimate the risk.

Testosterone plays a direct role here. Low testosterone accelerates bone loss, and men with hypogonadism are at substantially elevated fracture risk. The TRAVERSE trial itself found an unexpected signal: a higher rate of fractures in the testosterone group, underscoring that bone health in hypogonadal men is complex and requires active surveillance, not assumptions.

The Tracking Connection

Kairos™ treats bone health as a core pillar of hormonal wellness, not an afterthought. By integrating DEXA scan results, testosterone levels, vitamin D status, and physical activity data into a single health timeline, Kairos ensures that bone density trends are visible alongside the hormonal shifts that drive them. For men over 50, this kind of integrated tracking is not optional. It is the difference between catching bone loss at 5% and catching it after a fall.

Ready to start tracking?

Kairos™ tracks, scores, and interprets the symptoms of midlife hormonal change — for both women and men.

Get Started

More from the newsroom

Back to all articles